Phytochemical standardization, formulation and evaluation of oral hard gelatin capsules from Pinus eldarica bark extract

Document Type : Original Research Article

Authors

1 Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

2 Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

3 Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Objective:The extract of Pinus eldarica bark contains many polyphenolic compounds that were studied due to their high antioxidant, anti-inflammatory and anti-mutagenic effects. Therefore, the purpose of the present study was to conduct phytochemical standardization and develop hard gelatin capsules from the extract of P. eldarica bark.
Materials and Methods:Extraction was carried out by maceration method at room temperature for 72 hr using ethanol 70% followed by freeze drying. Quantification and standardization tests were performed using Folin-Ciocalteu method. Then, nine formulations were prepared containing different amounts of stearic acid (1-3%) and corn starch (3%, 10%, and 25%). Each formulation was characterized by FTIR and pharmacopoeial tests such as drug content, disintegration time, flowability parameters and drug release percent. The optimized formulation underwent stability studies at 75±5% humidity and 40±2°C.
Results:The total phenolic content of the extract in terms of gallic acid equivalent was 362.8±5.4 mg/g and the total procyanidin content in the extract was 174.386±2.5 mg/g. FTIR revealed no interaction between the components. The results presented that the best formulation of the capsules was achieved they contained 3% of stearic acid and 25% of corn starch. This formulation showed 91.69±0.33% of drug content, 9.36±0.02 min disintegration time and 83.02±0.81% release percent. Moreover, it showed good flowability. Stability studies on the optimized formulation displayed that the formulation was stable within 6 months in the accelerated condition.
Conclusion: In conclusion, results of the present phytopharmaceutical evaluations confirmed this product as a promising herbal capsule formulation.

Keywords

References

Afsharypuor S, Sanaty F. 2005. Essential Oil
Constituents of Leaves and Fruits of Pinus
eldarica Medw.J Essent Oil Res, 17:327-
328.
Anbu A, Samuel JSJ. 2018. Formulation and
Evaluation of Herbal Capsules Containing
Dried Ethanol Extract of Gnetum gnemon
Fruits. Int J Pharmacogn Phytochem Res,
12:273-280.
Babaee F, Safaeian L, Zolfaghari B, Haghjoo
Javanmard SH. 2016. Cytoprotective Effect
of Hydroalcoholic Extract of Pinus eldarica
Bark against H2O2-Induced Oxidative
Stress in Human Endothelial Cells. Iran
Biomed J, 20:161-167.
Bankoti K, Rana M, Bharadwaj M. 2012.
Accelerated stability study of herbal
capsules. IOSR-PHR, 2:1-6.
Bolandghamat S, Moghimi A, Iranshahi M.
2011. Effects of ethanolic extract of pine
needles (Pinus eldarica Medw.) on
reserpine-induced depression-like behavior
in male Wistar rats. Pharmacogn Mag,
7:248-253.
Carvalho HdO, Medeiros BJL, de Sá BM, C de
Araújo JT, Kawakami MYM, Favacho
HAS, Carvalho JCT. 2013. Study of
dissolution profiles and desintegration of
capsules containing the dried
hydroethanolic extract of Calophyllum
Esmaeili et al.
AJP, Vol. 11, No. 2, Mar-Apr 2021 178
brasiliense. Rev Bras Farmacogn, 23:194-
199.
Faridi P, Roozbeh J, Mohagheghzadeh A. 2012.
Ibn-Sina's Life and Contributions to
Medicinal Therapies of Kidney Calculi. Iran
J Kidney Dis, 6:339-45.
Ghadirkhomi A, Safaeian L, Zolfaghari B,
Agha Ghazvini MR, Rezaei P. 2016.
Evaluation of acute and sub-acute toxicity of
Pinus eldarica bark extract in Wistar rats.
Avicenna J Phytomed, 6:558-566.
Hosseinzadeh H, Khooei AR,
Khashayarmanesh Z, Motamed-Shariaty V.
2010. Antiurolithiatic activity of Pinus
eldarica medw: fruits aqueous extract in
rats. Urol J, 7: 232-237.
Huseini HF, Anvari MS, Khoob YT, Rabbani
S, Sharifi F, Arzaghi SM, Fakhrzadeh H.
2015. Anti-hyperlipidemic and antiatherosclerotic effects of Pinus eldarica
Medw. nut in hypercholesterolemic rabbits.
DARU, 23:32-37.
Iravani S, Zolfaghari B. 2011. Pharmaceutical
and nutraceutical effects of Pinus pinaster
bark extract. Res Pharmaceut Sci, 6:1-11.
Iravani S, Zolfaghari B. 2013. Green Synthesis
of Silver Nanoparticles Using Pinus
eldarica Bark Extract. Biomed Res Int,
2013:1-6.
Iravani S, Zolfaghari B. 2014. Phytochemical
analysis of Pinus eldarica bark. Res
Pharmaceut Sci, 9: 243-250.
Maimoona A, Naeem I, Saddiqe Z, Jameel K.
2011. A review on biological, nutraceutical
and clinical aspects of French maritime pine
bark extract. J Ethnopharmacol, 133: 261-
277.
Prathyusha C, Tegk M. 2013. Compatibility
studies of Donepezil with different
excipients by using HPLC and FTIR. J Adv
Pharmacy Edu Res, 3:273-279.
New Hope Network. 2020. Pycnogenol
Supplier Horphag Research Launches
Nutritional Ingredient Division. [online]
Available at:
<https://www.newhope.com/supply-newsamp-analysis/pycnogenol-supplierhorphag-research-launches-nutritionalingredient-divisi> [Accessed 13 August
2020].
Rohdewald P. 2002. A review of the French
maritime pine bark extract (Pycnogenol), a
herbal medication with a diverse clinical
pharmacology. Int J Clin Pharmacol Ther,
40: 158-168.
Rohdewald PJ. 2015. Update on the clinical
pharmacology of Pycnogenol(R). Med Res
Arch, 3:1-11.
Sadeghi M, Zolfaghari B, Jahanian-Najafabadi
A, Abtahi SR. 2016. Anti-pseudomonas
activity of essential oil, total extract, and
proanthocyanidins of Pinus eldarica Medw.
bark. Res Pharmaceut Sci, 11:58-64.
Sarvmeili N, Jafarian-Dehkordi A, Zolfaghari
B. 2016. Cytotoxic effects of Pinus eldarica
essential oil and extracts on HeLa and MCF7 cell lines. Res Pharmaceut Sci, 11:476-
483.
Simpson T, Kure C, Stough C. 2019. Assessing
the Efficacy and Mechanisms of
Pycnogenol(®) on Cognitive Aging From In
Vitro Animal and Human Studies. Front
Pharmacol, 10: 694-694.
Singleton VL, Orthofer R, Lamuela-Raventós
RM. 1999. Analysis of total phenols and
other oxidation substrates and antioxidants
by means of folin-ciocalteu reagent. Method
Enzymol, 299:152-78.
Tayarani-Najaran Z, Yazdian-Robati R, Amini
E, Salek F, Arasteh F, Emami A. The
mechanism of neuroprotective effect of
Viola odorata against serum/glucose
deprivation-induced PC12 cell death.
Avicenna J Phytomed, 2019; 9: 491-498.
The United States Pharmacopeia, United States
Pharmacopeial Convention, Inc. official
from May 1, 2007. Maritime Pine Bark
Extract – USP 30 NF25. P. 964-966.
The United States Pharmacopeia, United States
Pharmacopeial Convention, Inc. official
from May 1, 2019. General chapter volume
1– USP 42 NF37.
Uddin MS, Al Mamun A, Rashid M,
Asaduzzaman M. 2016. In-process and
finished products quality control tests for
pharmaceutical capsules according to
pharmacopoeias. Brit J Pharmaceut Res,
9:1-9.
Unit P, World Health Organization. WHO
guidelines on stability testing of
pharmaceutical products containing wellestablished drug substances in conventional
dosage forms. Geneva: World Health
Organization; 1996.WHO Technical Report
Series, No. 863, Annex 5.
Vyas T, Dash RP, Anandjiwala S, Nivsarkar M.
2011. Formulation and pharmacokinetic
evaluation of hard gelatin capsule
encapsulating lyophilized Vasa Swaras for
improved stability and oral bioavailability of
Preparation of oral Pinus eldarica bark extract capsules
AJP, Vol. 11, No. 2, Mar-Apr 2021 179
vasicine. Fitoterapia, 82:446-453.
Waterhouse, AL. 2002. Determination of Total
Phenolics. Current Protocol Food Analytic
Chem, 6:111-118.
Avicenna Journal of Phytomedicine
Volume 11, Issue 2
March and April 2021
Pages 168-179

Files

Share

How to cite

Statistics